Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase-1b Dose Escalation Study to Assess the Effect of NG11-2 on Radiation Induced Oral Mucositis in Patients With Head & Neck Cancer

NCT06669390 is registered in ClinicalTrials.gov with VasoDynamics Ltd as lead sponsor.

NCT NCT06669390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06669390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase-1b Dose Escalation Study to Assess the Effect of NG11-2 on Radiation Induced Oral Mucositis in Patients With Head & Neck Cancer
Lead sponsor
VasoDynamics Ltd
Phase
Phase 1
Overall status
Completed
Start date
May 22, 2023
Completion date
August 20, 2024
Enrollment
15 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

oral mucositis